Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Ophthalmology. 2010 Feb 13;117(6):1163–1168. doi: 10.1016/j.ophtha.2009.10.043

Table 2.

Confirmed Cases of Age-related Macular Degeneration.

Endpoint Vitamin E
(N=19,697)
Placebo
(N=19,724)
RR* (95% CI) P-value
Visually significant AMD 117 128 0.93 0.72–1.19 0.54
Advanced AMD 29 26 1.13 0.67–1.92 0.65
AMD with or without vision loss 280 313 0.90 0.77–1.06 0.20

Abbreviations: AMD, age-related macular degeneration; RR, relative risk; CI, confidence interval

*

Adjusted for age and aspirin and beta carotene treatment assignment